echoloc

Eikon Therapeutics Tech Stack

Clinical-stage biotech pipeline in oncology and neurological disease discovery

Biotechnology Research Millbrae, CA 201–500 employees Founded 2019 Privately Held

Eikon is a late-stage clinical biopharmaceutical company with 201–500 employees focused on oncology therapeutics and single-molecule imaging discovery. The tech stack (Databricks, Python, PostgreSQL, React, Tableau, ImageJ, GraphPad Prism, SAS, R) reflects a research-first organization: heavy emphasis on imaging data pipelines and statistical analysis, paired with foundational cloud infrastructure. Hiring pressure is concentrated in research (25 open roles) and healthcare operations (12), with senior and director-level positions dominating—a pattern consistent with late-stage clinical trials scaling and regulatory readiness. Active projects span global oncology trials, GLP toxicology studies, and regulatory submissions.

Tech Stack 16 technologies

Core StackDatabricks React TypeScript PostgreSQL Python C++ C# Java SAS Tableau Veeva R Microsoft Office Excel ImageJ GraphPad Prism

What Eikon Therapeutics Is Building

Challenges

  • Ensuring glp compliance
  • Risk identification and mitigation in trials
  • High-performance delivery of clinical studies
  • Meeting clinical trial timelines and budgets
  • Designing glp studies
  • Study start-up turnaround times
  • Scaling clinical study teams
  • Ensuring high-quality data delivery
  • Managing lab reference ranges
  • Regulatory compliance across clinical programs

Active Projects

  • Global oncology clinical trials
  • Early-stage clinical development trials
  • Clinical studies
  • Inspection readiness process implementation
  • Regulatory toxicology studies at cros
  • Author regulatory submissions
  • Clinical study management
  • Glp compliant toxicology studies
  • Capital markets offerings
  • Annual meeting of stockholders

Hiring Activity

Steady70 roles · 25 in 30d

Department

Research
25
Healthcare
12
Data
9
Legal
5
Ops
5
Engineering
3
Finance
3
Manufacturing
2

Seniority

Senior
31
Director
16
Mid
11
Manager
7
Principal
3
Intern
1
Junior
1

Notable leadership hires: Clinical Research Director, Intellectual Property Director, SEC Reporting Director

Company intelligence

Find more companies like Eikon Therapeutics by tech stack, pain points and active projects

Get started free

About Eikon Therapeutics

Eikon Therapeutics develops potential therapies in oncology and neurological disease using immune modulation, synthetic lethality, and single-molecule imaging platforms. The company was founded in 2019 and is headquartered in Millbrae, CA. Operations center on clinical trial execution, regulatory compliance, and translational research. Pain points center on GLP compliance, trial timeline management, and data quality assurance—typical friction points for organizations scaling from Phase 2/3 into regulatory submission and manufacturing readiness. The organization structure (heavy research and healthcare hiring, minimal engineering) reflects a biotech model where clinical and operational excellence drive value.

HeadquartersMillbrae, CA
Company Size201–500 employees
Founded2019
Hiring MarketsUnited States

Frequently Asked Questions

What is Eikon Therapeutics' tech stack?

Eikon uses Databricks, Python, PostgreSQL, React, Tableau, ImageJ, GraphPad Prism, SAS, R, C++, C#, Java, Veeva, and Microsoft Office. The stack emphasizes data analytics (Databricks, Python, SAS, R) and scientific visualization (Tableau, ImageJ, GraphPad Prism) alongside standard biotech platforms (Veeva for regulatory workflows).

Where is Eikon Therapeutics headquartered?

Eikon Therapeutics is headquartered in Millbrae, CA. The company was founded in 2019 and currently employs 201–500 people.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size